Raolta Er 500mg Tablet

Raolta ER 500mg Tablet contains the active ingredient Ranolazine. It belongs to a class of medications known as anti-anginal agents. Ranolazine is prescribed for the treatment of chronic angina pectoris, a condition characterized by chest pain or discomfort due to reduced blood flow to the heart muscle. Raolta ER 500mg Tablet is an extended-release formulation designed to provide sustained release of the medication over time.

Uses:

Raolta ER 500mg Tablet is used for the management of chronic angina pectoris in adults. It helps to improve exercise tolerance and reduce the frequency of angina episodes. Ranolazine works by inhibiting the late inward sodium current during cardiac repolarization, thereby reducing myocardial oxygen demand and improving coronary blood flow. It is often prescribed as adjunctive therapy in patients who have not achieved adequate symptom control with other anti-anginal medications.

Dosage:

The dosage of Raolta ER 500mg Tablet is determined by the healthcare provider based on various factors such as the patient’s medical history, renal function, and response to treatment. It is usually taken orally twice daily, with or without food. The tablet should be swallowed whole with a glass of water and should not be crushed or chewed. Patients should follow the prescribed dosage and administration instructions carefully.

Side Effects:

Common side effects associated with Raolta ER 500mg Tablet may include dizziness, headache, constipation, nausea, and drowsiness. These side effects are usually mild and transient. In some cases, more serious side effects such as QT prolongation, arrhythmias, or liver enzyme abnormalities may occur. Patients should report any adverse reactions to their healthcare provider promptly.

Precautions:

Before using Raolta ER 500mg Tablet, patients should inform their healthcare provider about any pre-existing medical conditions, allergies, or medications they are currently taking. It is essential to use caution in patients with a history of QT prolongation, arrhythmias, liver impairment, or renal impairment. Ranolazine may interact with other medications, so it’s crucial to review the patient’s medication regimen to prevent potential interactions.

When Not to Use:

Raolta ER 500mg Tablet is contraindicated in patients with a known hypersensitivity to Ranolazine or any other components of the medication. It should not be used concomitantly with strong inhibitors or inducers of CYP3A4, as this may lead to increased or decreased Ranolazine levels in the body. Patients with severe liver impairment or concurrent use of certain medications should avoid Raolta ER.